Combination hormonal therapy with tamoxifen plus fluoxymesteroneversus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis-Reference-Cited by-同舟云学术

Combination hormonal therapy with tamoxifen plus fluoxymesteroneversus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

Published:1991-02-15 Issue:4 Volume:67 Page:886-891
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ingle James N.,Long Harry J.,Twito Donald I.,Schaid Daniel J.,Cullinan Stephen A.,Gerstner James G.,Krook James E.,Mailliard James A.,Tschetter Loren K.,Windschitl Harry E.,Levitt Ralph,Pfeifle Delano M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference10 articles.

1. Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast Cancer

2. Additive hormonal therapy in women with advanced breast cancer

3. Fluoxymesterone Therapy in Advanced Breast Cancer

4. Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.

5. Unpublished data, 1989.

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding Sites of Anticancer Drugs on Human Serum Albumin (HSA): A Review;Protein & Peptide Letters;2022-08

2. A Temperature-Controlled Switch between Fürst–Plattner Rule and Anti-Fürst–Plattner Rule Ring Opening of 2,3-Epoxy-steroids with Various Halide Sources in the Presence of Imidazolium Ionic Liquids;ACS Omega;2021-10-05

3. Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic;Cancers;2021-10-03

4. Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview;Endocrine-Related Cancer;2021-02

5. Role of CD44 in breast cancer;Breast Disease;2020-02-11